StableStock 🐳(@StableStock):$MRNA has surged over 1,000% from its low. The next major catalyst? Cancer vaccine data. 🧬 On October 24, Moderna and Merck are expected to present Phase 3 data for their personalized mRNA cancer vaccine, V940, at ESMO 2026. With expectations running high, the results could be a key test of the technology's potential. $MRNA is available to trade on StableStock: https://t.co/vTNF6lgnUU For informational purposes only. Not investment advice.

2026.10.22 12:30

$MRNA has surged over 1,000% from its low. The next major catalyst? Cancer vaccine data. 🧬 On October 24, Moderna and Merck are expected to present Phase 3 data for their personalized mRNA cancer vaccine, V940, at ESMO 2026. With expectations running high, the results could be a key test of the technology's potential. $MRNA is available to trade on StableStock: For informational purposes only. Not investment advice.

StableStock 🐳@StableStock

2026.10.19 03:19

A defining week for AI, Big Tech, and biotech. $NVDA takes the spotlight as Jensen Huang delivers his GTC keynote, with sovereign AI and infrastructure in focus. $META and $TSLA earnings will test AI monetization and autonomous driving, while $LRCX, $TXN and $WDC offer fresh signals on chip and storage demand. Beyond AI, $MRNA and $MRK are set to unveil key Phase 3 cancer vaccine data. 📅 Here's what to watch this week ↓ #StableStockWeekAhead#